| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
| filingDate |
1992-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1995-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-950700075-A |
| titleOfInvention |
Combination of anti-albibi (erbB) -2 monoclonal antibodies and methods of use thereof |
| abstract |
The present invention relates to a combination of two or more monoclonal antibodies capable of preventing and treating human malignant diseases in which malignant cells overexpress gp185 erbB-2. Monoclonal antibodies of the combination recognize other epitopes of the gp185 expression product of erbB-2. Thus, antibodies do not cross react with each other. The combination is preferably to reduce the transformation product of the erbB-2 gene. In another embodiment, the combination does not essentially increase tyrosine postorylation of the gp185 phenotype. |
| priorityDate |
1992-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |